Press Archive - Page 2 of 34 - Stand Up to Cancer

Press

Read the latest Stand Up To Cancer press releases and announcements to see how we are making an impact.

PRESS RELEASES

March 31, 2019

Stand Up To Cancer Supported Clinical Trials Seeking To Extend CAR T-cell Therapy to Solid Tumors, Reported at AACR Annual Meeting

Stand Up To Cancer (SU2C) is helping scientists make progress in one of the most important areas of cancer research today: expanding the use of autologous CAR T-cell immunotherapy beyond leukemia and other blood cancers to solid tumors such as osteosarcoma and mesothelioma. If ultimately successful, the research could pave the way for a dramatic expansion of a therapy that has revolutionized treatment of blood malignancies but thus far, has had little impact on the solid tumors that make up most cancer cases.
Read More
March 30, 2019

The Pancreatic Cancer Collective Funds Two New Research Teams Using Artificial Intelligence to Identify High-Risk Pancreatic Cancer Populations

The Pancreatic Cancer Collective, the strategic partnership of Lustgarten Foundation and Stand Up To Cancer (SU2C), today announced two, million-dollar grants for computational approaches to identifying high-risk pancreatic cancer populations.
Read More
March 28, 2019

Stand Up To Cancer Hails Election of SU2C Team Leader as President-elect of American Association for Cancer Research

Stand Up To Cancer is hailing the election of active SU2C researcher and world-famous scientist, Antoni Ribas, MD, PhD, as the 2019-2020 president-elect of the American Association for Cancer Research, SU2C’s Scientific Partner.
Read More
March 27, 2019

Stand Up To Cancer Funded Research to be Presented March 30 – April 3 at AACR Annual Meeting

 Nobel Laureate James P. Allison, PhD, and other acclaimed researchers will be presenting their research funded by Stand Up To Cancer (SU2C) at the American Association for Cancer Research Annual (AACR) Meeting 2019 from March 29th to April 3rd, the Georgia World Congress Center (GWCC) in Atlanta.
Read More
March 25, 2019

Stand Up To Cancer Grants First Peggy Prescott Award In Colorectal Cancer Research

Stand Up To Cancer (SU2C) today announced the recipient of its inaugural Stand Up To Cancer Peggy Prescott Early Career Scientist Award in Colorectal Cancer Research, which was funded by Dallas Cowboys QB and SU2C Ambassador Dak Prescott in memory of his mother who passed away from the disease in 2013. The fellowship provides $50,000 in research funding over a two-year term to a rising star in the colorectal cancer field.
Read More
March 4, 2019

Pancreatic Cancer Collective Comments on Promising New Pancreatic Cancer

Lustgarten Foundation and Stand Up To Cancer, strategic partners in the Pancreatic Cancer Collective, offer comments on research published today in the journal Nature Medicine which describes a new therapeutic approach with promise for patients with pancreatic cancer.
Read More
February 20, 2019

STAND UP TO CANCER SETS $50 MILLION ENDOWMENT FUND GOAL TO ENSURE THE FUTURE OF ITS CATALYTIC MOVEMENT TO FUND GROUNDBREAKING, LIFE-SAVING CANCER RESEARCH

Looking to the future, Stand Up To Cancer (SU2C) today announced the establishment of the Stand Up To Cancer Legacy Endowment CIRCLE, with the goal of raising $50 million by the end of 2019.
Read More
January 29, 2019

Stand Up To Cancer Awards 2019 Laura Ziskin Prize in Translational Research to Drs. Silvia Formenti and Heather McArthur

Stand Up To Cancer awarded the 2019 Laura Ziskin Prize in Translational Research to two highly respected clinical investigators who will join in a bi-coastal collaboration to use radiation and immunotherapy pre-operatively to help the body create its own vaccine to fight breast cancer.
Read More
January 28, 2019

Stand Up To Cancer Tackles T-Cell Lymphoma with Dream Team Focused on CAR-based Strategies Launched in Honor of Meg Vosburg

Stand Up To Cancer announced here today the creation of an $8 million Dream Team of top scientists focused on finding therapies for T-cell lymphoma, a rare cancer of the blood and immune system, using chimeric antigen receptors (CARs) to trigger the immune system to attack and destroy cancerous cells.
Read More
January 16, 2019

WebMD Health Hero Awards Honor Researchers, Caregivers and Advocates Transforming the Impact of Cancer

WebMD celebrated the accomplishments and contributions of researchers, health care professionals and advocates who are helping to transform the impact of cancer during its Health Heroes event in New York City yesterday.
Read More

JOIN OUR COMMUNITY

Sign up to receive emails from Stand Up To Cancer.
   Please leave this field empty
Stand Up to Cancer

Thanks for signing up!
You will hear from us soon.